Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
68,652,138
-
Total 13F shares
-
1,038,443
-
Share change
-
+148,363
-
Total reported value
-
$5,482,000
-
Put/Call ratio
-
467%
-
Price per share
-
$5.28
-
Number of holders
-
28
-
Value change
-
+$532,990
-
Number of buys
-
19
-
Number of sells
-
7
Institutional Holders of Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) as of Q2 2021
As of 30 Jun 2021,
Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,038,443 shares.
The largest 10 holders included
MARSHALL WACE, LLP, Ikarian Capital, LLC, NORRIS PERNE & FRENCH LLP/MI, SUSQUEHANNA INTERNATIONAL GROUP, LLP, STATE STREET CORP, GOLDMAN SACHS GROUP INC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.